Reuters Gilead said on Sunday it had agreed to acquire the cancer-drug company Immunomidics for 21 billion. Immunomedic shares rose 106% on Monday following the news. Immunomidics, used to treat various forms of breast cancer, sells Drodelvi and is being evaluated for other possible signs of cancer. Trodelvie was approved …
Read More »
(Reuters) – Doctors in Europe will soon be able to treat COVID-19 patients with Gilead (GILD.O), antiviral drug, remdesivir, after the support of the health regulator set it on the path to becoming the first therapy for the disease on the continent. FILE PHOTO: Pharmaceutical company Gilead Sciences Inc is …
Read More »
FILE PHOTO: A Gilead Sciences, Inc. logo is seen outside the company headquarters in Foster City, California, USA. USA, May 1, 2018. REUTERS / Stephen Lam (Reuters) – Gilead Sciences Inc’s (GILD.O) Antiviral remdesivir could be priced up to $ 5,080 per course based on the benefits shown in COVID-19 …
Read More »